Abstract
Biologic therapies have emerged as important treatments in chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, and are now garnering more attention in the vasculitides. These agents, including tumor necrosis factor-alpha inhibitors, B-cell-depleting agents, interferon-alpha, and some antiviral treatments, target specific components of the immune system and may have lower side effect risk profiles than the conventional immunosuppressives and cytotoxic agents. This article addresses the encouraging data and the possible pitfalls of these new therapeutic options, thus far evaluated mostly by case reports, small series, and open-label trials. Confirming the efficacy of existing and newer therapies will require further clinical investigation through randomized placebo-controlled studies to identify the proper doses and treatment schedules and single out those drugs that may expose patients to dangers that outweigh the potential benefits.
References
Mar 17, 1994·The New England Journal of Medicine·R MisianiG Vendramin
Jan 1, 1997·Rheumatology International·M FieldG Gallagher
Sep 1, 1999·Alimentary Pharmacology & Therapeutics·J L CallejaP Escartín
Apr 17, 2001·Annals of the Rheumatic Diseases·A A den BroederL B van de Putte
Jan 5, 2002·Arthritis and Rheumatism·F CantiniI Olivieri
Jan 17, 2002·Rheumatology·M E McCainW E Davis
Apr 6, 2002·Rheumatology·P AiròP Toniati
Sep 5, 2002·Arthritis and Rheumatism·Gaye CunnaneDavid I Daikh
Oct 5, 2002·Rheumatology·P BartolucciL Guillevin
Dec 7, 2002·Rheumatology·P A Livermore, K J Murray
Dec 31, 2002·Blood·Domenico SansonnoFranco Dammacco
Mar 14, 2003·Annals of the Rheumatic Diseases·A L TanD McGonagle
Mar 15, 2003·BMJ : British Medical Journal·Marcel P M ten TusscherWillem L Diemont
May 22, 2003·Annals of the Rheumatic Diseases·L UngerH G Nüsslein
Nov 18, 2003·Allergy·H-U SimonM Schmitz
Dec 3, 2003·Annals of the Rheumatic Diseases·P LamprechtW L Gross
Dec 11, 2003·Chest·Claus KroegelAngelika Reissig
Jun 10, 2004·Arthritis and Rheumatism·L GuillevinUNKNOWN French Vasculitis Study Group
Jul 13, 2004·Arthritis and Rheumatism·Gary S HoffmanPatrick Liang
Jul 17, 2004·European Journal of Gastroenterology & Hepatology·Harry L A JanssenRobert A de Man
Dec 14, 2004·Arthritis and Rheumatism·Charles L Christian
Dec 18, 2004·Current Opinion in Rheumatology·Patrick Liang, Gary S Hoffman
Jan 11, 2005·Arthritis and Rheumatism·Karina A KeoghUlrich Specks
Mar 8, 2005·Arthritis and Rheumatism·Patrice CacoubJean-Charles Piette
Apr 14, 2005·Journal of Hepatology·Cesare MazzaroGabriele Pozzato
Apr 21, 2005·Rheumatology·A Della RossaS Bombardieri
May 5, 2005·The Journal of Pediatrics·Jane C BurnsMarian E Melish
May 25, 2005·Journal of Internal Medicine·P Eriksson
Citations
Dec 14, 2011·Reumatología clinica·Mariano Arturo Díaz-Orta, Jorge Rojas-Serrano
Mar 1, 2008·Reumatología clinica·Paloma Vela Casasempere
Jan 14, 2020·Veterinary Dermatology·Pauline PanzutiDidier Pin
May 10, 2008·Epidemiology and Infection·M J TrepkaF Leguen
Jul 9, 2020·Arquivos brasileiros de cardiologia·José Albuquerque de Figueiredo NetoEvandro Tinoco Mesquita
May 25, 2013·Circulation Research·Matthew T RondinaGuy A Zimmerman